Korea FilingsFull brief — $39

SINSIN PHARMACEUTICAL Co., LTD.

신신제약(주) · KOSDAQ: 002800 · Pharmaceuticals and medicinal chemicals

Key facts

Korean name
신신제약(주)
Market / ticker
KOSDAQ · 002800
Industry
Pharmaceuticals and medicinal chemicals
Established
1959-09-09
Fiscal year ends
December
Website
www.sinsin.com
DART corp code
00136448
Latest revenue
₩113.8B (FY2025)

Items worth checking

No rule-based items found in the latest annual report or the last 12 months of filings. This is a limited automated check, not a clean bill of health.

Financial summary

KRWFY2023FY2024FY2025
Revenue₩102.6B₩106.4B₩113.8B
Operating income₩6.0B₩6.9B₩10.8B
Net income₩4.6B₩4.8B₩9.3B
Total assets₩124.4B₩129.5B₩137.5B
Total liabilities₩62.3B₩63.9B₩63.0B
Total equity₩62.1B₩65.6B₩74.5B
Share capital₩7.6B₩7.6B₩7.6B

Consolidated statements · FY2025 operating margin 9.5% · liabilities to equity 85% · Annual report FY2025 (Korean original)

Auditor opinions

PeriodAuditorOpinion
Term 63 (current)우리회계법인Unqualified
Term 62 (prior)신한회계법인Unqualified
Term 61 (two years prior)신한회계법인Unqualified

Largest shareholder history

DateLargest shareholder (Korean)StakeCause (Korean)
이병기임원퇴임
이병기장내매수
2022년 12월 19일이병기변경전 최대주주 본인의 상속재산 분할 완료에 따른 변동

Recent filings

DateFilingOriginal
2026-08-14Half-year report (2026.06)DART
2026-07-01Officer / major shareholder ownership reportDART
2026-05-22Material management matterDART
2026-05-22Material management matterDART
2026-05-15Quarterly report (2026.03)DART
2026-04-30Market segment reassignmentDART
2026-03-26Annual general meeting resultsDART
2026-03-18Annual report (2025.12)DART
2026-03-18Audit report submittedDART
2026-03-12Amended: Notice of shareholders meetingDART
2026-03-11Proxy solicitation reference documentDART
2026-03-11Notice of shareholders meetingDART
2026-03-11Amended: Resolution to convene shareholders meetingDART
2026-02-10Large shareholding (5%+) reportDART
2026-02-09Resolution to convene shareholders meetingDART
2026-02-09Cash / in-kind dividend decisionDART
2026-02-02Revenue or profit structure changed materiallyDART
2025-12-12Record date / shareholder register closure setDART
2025-11-19Material event reportDART
2025-11-14Quarterly report (2025.09)DART

Showing the 20 most recent of 22 filings. The full brief lists all of them.

Full brief on SINSIN PHARMACEUTICAL Co., LTD. — $39 Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Pharmaceuticals and medicinal chemicals

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.